Home › with Excess of Blasts Refractory Anemia › Ohio
with Excess of Blasts Refractory Anemia clinical trials in Ohio
4 studies for with Excess of Blasts Refractory Anemia are looking for participants at sites in Ohio.
Cities in Ohio
Luspatercept + Darbepoetin in MDS
- The Ohio State University - The James Cancer Hospital and Solove Research Institute: Comprehensive Cancer Center (, Columbus
RecruitingPhase 2Healthy volunteers welcome
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT07096297Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis in Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation
- Ohio State University Comprehensive Cancer Center, Columbus
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT07249346A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
- Ohio State University Comprehensive Cancer Center (OSUCCC) - The James Cancer Hospital and Solove Research Institute, Columbus
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Apr 30, 2026 · NCT04256317HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- Cincinnati Children's Hospital Medical Center, Cincinnati
RecruitingPhase 2
3 Months · All sexes · Updated Nov 12, 2025 · NCT02143830From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.